- Research
- Open access
- Published:
Cannabis use is not associated with altered levels of physical activity: evidence from the repeated cross-sectional Belgian Health Interview Survey
Journal of Cannabis Research volume 7, Article number: 22 (2025)
Abstract
Background
Several studies have suggested a positive effect of occasional cannabis consumption on the frequency of leisure-time physical activity, possibly due to more motivation before, more enjoyment during, and better recovery after engaging in leisure-time physical exercise. While such an effect would contradict the stereotypical image of lower physical activity levels in cannabis users as compared to non-users, evidence has been mixed at best. The current study investigated this proposed association in a representative sample of the Belgian population.
Methods
Data from four waves of the Belgian Health Interview Survey (HIS; repeated cross-sectional survey; 2001 – 2018) were used in a regression and propensity matching analysis to examine the association between past-month cannabis use and physical activity levels, while controlling for potentially confounding variables. A total of n = 19,936 individuals (48.9% female) aged 15–64 years were included in the analysis. We modelled physical activity in function of past-month cannabis use while adjusting for potential confounders.
Results
Both the regression analysis and the propensity-matching analysis revealed no evidence in favor of a positive effect of past-month cannabis use on physical activity level (estimated OR = 0.97, 95% CI = [0.74, 1.28] and estimated RR = 0.90, 95% CI = [0.70; 1.16] respectively). Descriptive analyses of baseline characteristics suggested some clear differences between users and non-users that were in line with previous studies.
Conclusions
There was no evidence suggesting that past-month cannabis users have better or worse physical activity levels compared to non-users in the Belgian population aged 15–64 years.
Introduction
Over the past few years the subject of cannabis use and its effects on physical and mental health has become a very popular topic, especially in the debate on legalization of recreational cannabis use in many countries (The Lancet Regional Health- Europe 2021). According to the United Nations world drug report (European Monitoring Centre for Drugs and Drug Addiction 2022), cannabis is the most popularly used illicit drug in the general population, with an estimated 27.3% of all people aged between 15 and 64 having used cannabis at least once in their lifetime. Furthermore, the report revealed an increasing trend in the average potency of the used substances (measured as the concentration in delta- 9-tetrahydrocannabinol, %THC, the most important psychoactive component of cannabis) between 2010 and 2020.
In Belgium, where both possession and consumption of recreational cannabis is illegal, but decriminalized, the proportion of adults aged 15 to 64 years who used cannabis at least once in their lifetime increased from 15% in 2013 to 22.6% in 2018 (Gisle and Drieskens 2018). This increasing trend was also observed in past-year use, with an increase from around 5% in 2004–2013 to around 7% in 2018, and past-month cannabis use with around 3% in 2001–2013 to 4.3% in 2018 (Gisle and Drieskens 2018). This relatively high and increasing prevalence, both worldwide and in Belgium, together with increasing potency highlight the importance of extensive research on the health effects of cannabis.
Apart from the known adverse effects (mainly related to the psychoactive THC component) on the cardiovascular system (Ghosh and Naderi 2019; Page et. al 2020), the respiratory system (Gates et al. 2014; Winhusen et al. 2019), Body Mass Index (BMI; (Fearby et al. 2022), and mental health (Moore et al. 2007), some studies point towards potential health benefits of recreational cannabis consumption (predominantly attributed to the cannabidiol component, CBD; (YorkWilliams 2019; Gillman et. al 2015; Ong et. al 2021; Gibson et al. 2023; Korn et al. 2018). Particularly, an increasing number of studies suggest that, on average, people who use cannabis (referred to as users) tend to engage more in physical activity compared to people who do not use cannabis (referred to as non-users, (YorkWilliams 2019; Gillman et. al 2015; Ong et. al 2021; Gibson et al. 2023; Korn et al. 2018).
YorkWilliams et al. (2019) conducted an online survey in the United States of America to investigate the link between cannabis use and physical exercise among adults living in the states where cannabis is fully legalized. The authors found that participants using cannabis in close proximity to exercise performed on average 30.2 min (95% Confidence Interval (CI) = [2.4; 58.0]) more anaerobic exercise per week compared to participants who did not. Moreover, the majority of users reported greater enjoyment while exercising and better recovery afterwards. Though this study did not include a non-using control group and collected data using self-reports, the results nonetheless highlight potential benefits of occasional cannabis consumption on physical activity. Echoing these findings, Smith et al. (Smith et al. 2021) observed that ever having used cannabis was associated with higher odds of physical activity, with a similar pattern also observed by Ong et al. (2021).
Three main components that may underlie this potential association are commonly suggested: heightened motivation to exercise (YorkWilliams 2019; Gibson 2024), increased enjoyment during exercise (Dietrich 2004), and faster recovery after exercise (Schubert et. al 2022; Kozela et al. 2013; Nagarkatti et al. 2009). The first two components have often been related to the “runner’s high” (i.e., feeling euphoric and relaxed after prolonged anaerobic activity). Related to faster recovery after exercise, the anti-inflammatory effects of cannabis (both THC and CBD) are assumed to play a crucial role. (Gillman et. al 2015; Kozela et al. 2013; Nagarkatti et al. 2009).
Gibson and Bryan (Gibson 2024) illustrated the acute effect of cannabis consumption on subjective experiences during exercise using a within-subjects crossover design. In this study, experiences such as negative and positive affect, exercise enjoyment and the runner’s high were measured during physical activity with and without prior cannabis consumption. Results revealed that positive- and negative affect while engaging in physical exercise were respectively elevated and decreased in the cannabis condition. Additionally, lower levels of physical pain and a stronger runner’s high were also observed when using cannabis.
Importantly, there is some evidence suggesting that cannabis (and particularly THC) has important interactions with both the human endocannabinoid system (Hanney 2022) and neural reward processing system (Bloomfield et al. 2016), which could explain the runner’s high, increased enjoyment, and elevated motivation associated with cannabis use (see also 11 for a review).
So far, research investigating the association between cannabis use and physical activity has been somewhat limited, and has led to inconclusive results. On the one hand, studies suggest that cannabis either has no effect (Gibson et al. 2023; YorkWilliams et al. 2020), or even a detrimental effect on exercise performance (Pesta et al. 2013; Kennedy 2017). On the other hand, there are the previously mentioned studies that point towards a potential positive association between occasional cannabis consumption and activity (YorkWilliams 2019; Gillman et. al 2015; Ong et. al 2021; Gibson et al. 2023; Korn et al. 2018). Taken together, evidence regarding the aforementioned association is mixed at best, warranting the need for further investigation. This study aimed to further explore the association between past-month cannabis use and physical activity by analyzing data from a large national health survey (the Belgian Health Interview Survey, HIS, 2001–2018; (Gisle and Drieskens 2018; Demarest 2018; Demarest et al. 2013; Sciesano n.d.). To this end, we conducted a survey-weighted logistic regression with propensity score adjustment as well as a propensity score matched analysis. To the best of our knowledge, this is the first investigation of this association in a representative sample of the general Belgian population.
Methods
Dataset
The data used in this study were part of the HIS dataset, resulting from a repeated cross-sectional survey conducted among the Belgian population (Gisle and Drieskens 2018; Demarest 2018; Demarest et al. 2013; Sciesano n.d.) by Sciensano every four to five years. This survey gathers data on a wide range of health- and lifestyle-related topics from a large, representative sample of the Belgian population. Currently, data from six waves are available (years 1997, 2001, 2004, 2008, 2013 and 2018). The current study used data from wave two (2001) up to, and including wave six (2018) as certain variables of interest were not (or only partly) recorded in the first wave. The final sample following pre-processing (see Supplementary Material 1) consisted of 19,936 individuals aged 15–64 years. Data were weighted using the post-stratification weights of the HIS dataset to represent the target Belgian population.
Measures
Dependent variable
The dependent variable was ‘Leisure-time physical activity’ consisting of two response categories (‘mainly sedentary activities’ and ‘light/intensive physical activities’) in order to allow for binary logistic regression (see Supplementary Material 1 for more information on the creation of this variable).
Independent variable
The main predictor variable of interest, past-month cannabis use, was measured by a binary variable indicating cannabis use in the past 30 days. With this variable, we aimed to better target current users as opposed to past-year or even lifetime users (see Discussion).
Covariates
Covariates were selected based on the literature suggesting a potential association with either the dependent or the independent variable. By including these covariates (see Supplementary material 1), we aimed to minimize potential confounding of the relationship between past-month cannabis use and physical activity. Selected covariates were age (Jeffers et al. 2021; Trost et al. 2002; Mota and Esculcas 2002), education (Jeffers et al. 2021; Lynskey and Hall 2000; Macleod et al. 2004; Shaw and Spokane 2008), income (Jeffers et al. 2021; Ford et al. 1991), sex (Jeffers et al. 2021; Mota and Esculcas 2002; Cranford et al. 2009; Carliner et al. 2017), the Global Activity Limitation Indicator (GALI, (Oyen et al. 2006), degree of urbanization (Reis et al. 2004), and depression and anxiety (Macleod et al. 2004; Lev-Ran et al. 2014; Degenhardt et al. 2003; Crippa et al. 2009; Hayatbakhsh et al. 2007). Additionally, we included the variables Year of the survey and Province of residence to further control for differences in time and geographical location.
Statistical analyses
Regression analysis
As a result of the stratified multi-stage clustered sampling design of the HIS, some methodological aspects need to be taken into consideration (see Supplementary Material 1 for the exact motivation). Both unequal selection probabilities for individuals in the target population, and the clustered structure (e.g., people nested within households) were taken into account by using the surveylogistic procedure in SAS version 9.4 (SAS Institute Inc. 2016). Additionally, we used estimated propensity scores as predictors (i.e., the estimated probability of using cannabis in the last 30 days given the baseline covariates, estimated here using a logistic regression model that takes into account the complex survey design; see and Supplementary Material 1). This also allowed us to evaluate differences in baseline covariates between users and non-users. The final regression model contained physical activity as the outcome and all covariates together with past-month cannabis use and the estimated propensity score as predictors. Model-building proceeded via the method of double-variable selection. Sampling weights representing how many individuals in the target population were represented by each individual in the sample were used (see Supplementary Material 1).
Propensity score matching analysis
A potential drawback of the regression framework is that the model coefficients have a subtle interpretation: these capture the natural logarithm of the estimated odds ratio comparing two levels of a covariate (e.g. users vs non-users). An alternative analysis yielding more easily interpretable estimates, and that is less vulnerable to extrapolation, uses propensity scores to match comparable non-users to past-month cannabis users, delivering estimates of the average effect of cannabis in the user population (see Supplementary Material 1). This effect expresses how much the percentage of physically active users would change in the users if they had not used cannabis in the last 30 days. Analysis of the matched dataset was carried out with the surveyfreq procedure in SAS software (SAS Institute Inc. 2016).
Sensitivity analysis
We conducted a sensitivity analysis to evaluate the robustness of our results against minor changes to either the regression model or the propensity estimation model. To this end, we ran the same regression analysis with all two-way interactions between covariates included, both for estimating the propensities and in the final regression model, as well as analyses including a quadratic effect of age in the propensity score model and the final regression model (see Supplementary Material 2).
Results
Descriptives
The current section discusses the weighted and unweighted descriptive summary statistics of the 19,936 participants included in the statistical analyses (i.e., the complete cases remaining after 42,959 incomplete/inapplicable observations were omitted following pre-processing, see Supplementary Material 1).
Description of the sample (unweighted summary statistics)
Past-month cannabis use was relatively rare in the sample with only 3.1% of respondents (n = 618) answering positively to this question (Fig. 1A). 71.3% of respondents (n = 14,223) were in the category of light/intensive activity (Fig. 1B). An overview of all variables can be found in Table 1.
Unweighted descriptive summary statistics for all variables included in the analysis. Legend: The current plots provide insight into the variable distributions in study sample based on pre-processed, unweighted data Y-axes represent percentages, except for panel G (Age) where it represents a density
Description of the target population (weighted summary statistics)
In the target population, weighted descriptives revealed that past-month cannabis use was relatively rare with only 2.8% (Fig. 2A). 73.1% of the target population was estimated to be part of the light/intensive activity category (Fig. 2B). An overview of all variables can be found in Table 1.
Regression results
The regression analysis revealed no statistically significant effect of past-month cannabis use at the α = 0.05 significance level when adjusting for the estimated propensity score and covariates (Table 2, see Table 3 for estimated odds ratios and confidence intervals). The odds ratio (OR) of belonging to the light/intensive physical activity group for past-month cannabis users and non-users was estimated to be 0.97 (95% CI = [0.74, 1.28], p = 0.84).
Propensity score matching results
The estimated frequency of active individuals in the user group was 71.8% (95% CI = [66.5; 76.9]), whereas the estimated frequency of active individuals in the matched non-user group was 74.6% (95% CI = [70.2; 79.1]), suggesting that users, had they not used cannabis in the last 30 days, would have a slightly greater probability of being in the active group. The resulting Risk Ratio (RR) of active group membership for users compared to users, had they not been using, was estimated to be 0.90 (95% CI = [0.70; 1.16]), suggesting that past-month cannabis use does not affect the risk of being in the active group (Fig. 3).
Estimated risks of active group membership for cannabis users and matched non-users. Legend: Error bars represent 95% confidence intervals. As the current estimates resulted from a propensity-matching analysis in which non-users were matched to users, the estimates reflect estimated percentages of active group membership in cannabis users and cannabis users, had they not used cannabis
Sensitivity analysis
All additional analyses resulted in minor quantitative, rather than qualitative changes. The same conclusion that past-month cannabis users and non-users show similar levels of leisure-time physical activity was reached in all additional analyses (see Supplementary Material 2).
Discussion
The current study examined whether past-month cannabis use has a positive effect on the average amount of leisure time physical activity in a large and representative sample of the Belgian population. Additionally, our descriptive analyses provide insights into the defining characteristics of both the current users and non-users. Two complementary analyses revealed no evidence of a positive relation between past-month cannabis use and leisure-time physical activity after adjusting for potential confounders and the complex survey design.
The observation of no effect of past-month cannabis use on physical activity challenges a set of previously discussed recent studies reporting potential benefits (YorkWilliams 2019; Gillman et. al 2015; Ong et. al 2021; Gibson et al. 2023; Korn et al. 2018). The current study therefore serves as a cautionary note against premature conclusions, and underscores the need for further investigation of this important association. Moreover, the absence of an effect in the present study suggests that current cannabis users are not necessarily at a disadvantage in terms of physical activity levels (but note that absence of evidence does not equal evidence of absence). Furthermore, the suggested lack of association between cannabis use and physical activity can also be informative for other factors previously linked to cannabis use (e.g. obesity and cannabis consumption; Fearby et al. 2022). Finally, the propensity score model revealed that the probability of reporting past-month cannabis use decreased with age, was higher for men than women, and was higher for people with a generalized anxiety disorder, in line with previous findings (Trost et al. 2002; Crippa et al. 2009; Hayatbakhsh et al. 2007).
Our sample also better covers the effects of cannabis as it is used in daily life, compared with studies focusing on unrealistically smaller doses or recruiting subjects with a likely positive attitude towards cannabis use. Moreover, the use of the HIS dataset enabled us to easily adjust for other important health-related variables. Finally, by combining information from different HIS editions, we were able to study a relatively large number of cannabis users (a group that is usually relatively small in single samples).
At the methodological level, in the context of regression adjustment, the use of propensity scores (Hernán and Robins 2020) adds several important advantages: firstly, it allows for evaluation of the similarity of users and non-users in baseline covariates, a task that would otherwise be virtually impossible given the dimensionality of the data. Secondly, matching on the propensity scores provided a simpler interpretation in terms of the effect of cannabis in the users, while preventing extrapolation when no similar users and non-users (in terms of their propensity to use cannabis) can be found. Finally, the use of propensity scores, together with baseline covariates has been shown to make tests of the causal null-hypothesis more robust against potential misspecification of the regression model, by still delivering valid results in that case so long as the propensity score model is correctly specified (Vansteelandt and Daniel 2014).
Besides our large and representative sample and informative analyses, there are some considerations to keep in mind when interpreting the current findings. Firstly, although we specifically selected the variable of past-month cannabis use instead of past-year or even lifetime-cannabis use in order to better target regular users, this variable does not perfectly capture this target group. One can imagine that some of the respondents reporting past-month use were in fact first time users and might have not used thereafter, or that some users might have provided false information regarding their use, due to the illicit nature of cannabis in Belgium (though measures were taken to limit this influence, e.g., by having participants provide this information anonymously in a sealed envelope). Furthermore, no information was available on how cannabis was consumed in relation with leisure-time physical activity (before, during or after exercise), as was an important aspect in previous studies (YorkWilliams 2019), nor were we able to account for frequency/intensity of cannabis use or the consumption of other drugs. Finally, the current dataset did not have information regarding the precise cannabinoids that were used in the past month.
Similarly, while the variable leisure time physical activity provides a proxy for an individual’s general level of physical exercise, the absence of an association with past-month cannabis use may also be due to this variable not adequately capturing the type, intensity, or amount of participants’ physical activity. Akin to the potential effect of social desirability in reporting past-month cannabis use, respondents may have overreported the amount of physical exercise they got on a weekly basis. Alternative variables in the HIS dataset were considered (e.g., the binary indicators of meeting the World Health Organization (WHO) recommendations on health enhancing physical exercise), but were not selected due to this information being recorded for our selected HIS editions.
Finally, even though we selected important control variables, the possibility remains that some potential confounders were not available or included in the models. Importantly, the cross-sectional nature of the study additionally complicates a valid confounding adjustment as it is difficult to disentangle causes from effects of cannabis use. Moreover, we note the possible bias resulting from a complete case analysis (i.e., omitting missing data, see Supplementary Material 3 for a discussion) and the added value of the more efficient (but more complex) method of multiple imputation (Li et al. 2015). Finally, though we conducted a sensitivity analysis, it remains hard to formally verify the adequacy of logistic regression models, especially with complex survey designs (as these designs often violate core assumptions of standard logistic regression).
It is equally important to evaluate our findings in light of both the time and location in which these data were collected. Data collection for the included HIS editions dates back to as early as 2001. Since then, societal attitudes and actual use of cannabis have potentially changed. A recent study investigating the attitudes towards medicinal cannabis use in the general population of Belgium, for example, observed that a large portion of the respondents would be open to trying medical cannabis should this be needed (Pav et al. 2024). These generally high levels of acceptance and use, specifically in the Flemish region, were also reflected in the relatively large and increasing number of positive cannabis samples examined by the doping control laboratory in Ghent (Van Eenoo and Delbeke 2003). Taken together with the increasing trends in average potency and consumption frequency (Gisle and Drieskens 2018), it seems reasonable to expect differences in the association between cannabis use and physical activity over time. While data from the 2023 HIS edition were not available yet, it would be an interesting follow-up to repeat a similar analysis with these most recent data.
Another important contrast with previous studies is that our sample targeted the Belgian population as opposed to the majority of studies on the current effect taking place in the United States of America. As opposed to Belgium, a large number of states have legalized recreational and/or medical cannabis use (Cheng et al. 2003). Consequently, cannabis users in studies conducted in these states may show important differences with the user population queried in Belgium, both in frequency and accurate reporting of cannabis consumption.
Considering that cannabis use in the current and previous studies was mainly considered for recreational purposes, an interesting outstanding question is whether the association between cannabis use and physical exercise depends on the motivation for consumption (i.e., recreational versus medical). In the current study, no distinction could be made between these two types of users. Potentially, cannabis use for medical purposes could show a stronger (albeit negative) association with physical exercise, considering the likely presence of other health-related issues in this population. Follow-up studies with more information on the type of cannabis use will be important to differentiate the effect of cannabis use and the effect of general health status.
Additionally, despite the lack of evidence that people who use cannabis are at a disadvantage regarding physical activity levels, we argue that it is still crucial for public health agencies to continue promoting adequate levels of physical exercise, especially in the population of cannabis users. Despite the fact that the effects of cannabis use on mental and physical health are not yet fully-understood, increased levels of physical activity could potentially offset some of the commonly suggested adverse effects (predominantly of THC), such as on respiratory health (Pinckard et al. 2019), cardiovascular disease (Duncan et al. 2021), or mental health (Smith and Merwin 2020).
Taken together, our findings highlight possible important directions for future research. Firstly, using variables that better capture the constructs of interest (e.g., better/objective measures of cannabis use or physical activity) could help to draw more firm conclusions on the proposed association. A worthwhile follow-up study in this regard would include data from fewer waves for a more sensitive measure of physical activity and/or cannabis use. Secondly, as the possibility of unmeasured confounders remains an issue for observational studies, it will be of interest to revisit the considered scientific question based on longitudinal data and to explore how other factors may contribute to this important association (e.g., the role of exercise enjoyment, sleep quality, bodily pain, or the presence of cannabis use disorder). Finally, future studies, both on the current topic and more generally, could benefit from the incorporation of propensity based methods as applied here.
Conclusion
We examined the association between past-month cannabis use and leisure-time physical activity in the Belgian population. To this end, we conducted two complementary analyses (a regression analysis and a propensity score matching analysis) on the Belgian Health Interview Survey dataset (2001–2018), a large and representative sample of our target population. Both analyses did not support a positive (or negative) effect of past-month cannabis use on physical activity levels while controlling for potential confounders and the complex survey design. While we argue that the stereotypical image of cannabis users having more sedentary lifestyles should be critically reevaluated in light of our and other research, we still consider promoting sufficient levels of physical exercise to be of utmost importance, both in user and non-user populations.
Data availability
The data that support the findings of this study are available from Sciensano upon request.
Abbreviations
- CBD:
-
Cannabidiol
- THC:
-
Delta-9-tetrahydrocannabinol
- BMI:
-
Body Mass Index
- CI:
-
Confidence Interval
- HIS:
-
Health Interview Survey
- GALI:
-
Global Activity Limitation Indicator
- OR:
-
Odds Ratio
- RR:
-
Risk Ratio
- WHO:
-
World Health Organization
References
Bloomfield MA, Ashok AH, Volkow ND, Howes OD. The effects of Δ9-tetrahydrocannabinol on the dopamine system. Nature. 2016;539(7629):369–77.
Carliner H, Mauro PM, Brown QL, Shmulewitz D, Rahim-Juwel R, Sarvet AL, et al. The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002–2014. Drug Alcohol Depend. 2017;170:51–8.
Cheng Y, Macera C, Addy C, Sy F, Wieland D, Blair S. Effects of physical activity on exercise tests and respiratory function. Br J Sports Med. 2003;37:521–8.
Cranford JA, Eisenberg D, Serras AM. Substance use behaviors, mental health problems, and use of mental health services in a probability sample of college students. Addict Behav. 2009;34(2):134–45.
Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, et al. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol Clin Exp. 2009;24(7):515–23.
Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression: association between cannabis use and depression. Addiction. 2003;98(11):1493–504.
Demarest S, Van der Heyden J, Charafeddine R, Drieskens S, Gisle L, Tafforeau J. Methodological basics and evolution of the Belgian health interview survey 1997–2008. Arch Public Health. 2013;71(1):24.
Demarest S, Berete F, Braekman E, Charafeddine R, Drieskens S, Gisle S, Van der Heyden J. Study Protocol HIS 2018. Report No.: 30/E/018 V1. Belgium (BE): Sciensano; 2018.
Dietrich A. Endocannabinoids and exercise. Br J Sports Med. 2004;38(5):536–41.
Duncan M, Patte K, Leatherdale S. Hit the chronic. physical activity: are cannabis associated mental health changes in adolescents attenuated by remaining active? Soc Psychiatry Psychiatric Epidemiol. 2021;56:141–52.
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2022: Trends and Developments. Luxembourg: Publications Office of the European Union; 2022.
Fearby N, Penman S, Thanos P. Effects of Δ9-Tetrahydrocannibinol (THC) on obesity at different stages of life: a literature review. Int J Environ Res Public Health. 2022;19(6):3174.
Ford ES, Merritt RK, Heath GW, Powell KE, Washburn RA, Kriska A, et al. Physical activity behaviors in lower and higher socioeconomic status populations. Am J Epidemiol. 1991;133(12):1246–56.
Gates P, Jaffe A, Copeland J. Cannabis smoking and respiratory health: consideration of the literature: Cannabis and respiratory health. Respirology. 2014;16(5):655–62.
Ghosh M, Naderi S. Cannabis and cardiovascular disease. Curr Atheroscler Rep. 2019;21(6):21.
Gibson L, Bryan A. Running high: Cannabis users’ subjective experience of exercise during legal market cannabis use versus no use in a naturalistic setting. Cannabis Cannabinoid Res. 2024;9(4):e1122.
Gibson L, Skrzynski C, Giordano G, Bryan A. A daily diary investigation of cannabis use and its diet and exercise correlates. Front Psychol. 2023;14:1217144.
Gillman AS, Hutchison KE, Bryan AD. Cannabis and exercise science: a commentary on existing studies and suggestions for future directions. Sports Med. 2015;45(10):1357–63.
Gisle L, Drieskens S. Health Interview Survey 2018: Drug Use. Brussels: Sciensano; 2018. Report No.: D/2019/14.440/59.
Haney M. Cannabis use and the endocannabinoid system: a clinical perspective. Am J Psychiatry. 2022;179(1):21–5.
Hayatbakhsh MR, Najman JM, Jamrozik K, Mamun AA, Alati R, Bor W. Cannabis and anxiety and depression in young adults. J Am Acad Child Adolesc Psychiatry. 2007;46(3):408–17.
Hernán MA, Robins JM. Causal Inference: What If. Boca Raton: Chapman & Hall/CRC; 2020.
Jeffers AM, Glantz S, Byers A, Keyhani S. Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US. JAMA Netw Open. 2021;4(11):e2136571.
Kennedy MC. Cannabis: exercise performance and sport. A systematic review. J Sci Med Sport. 2017;20(9):825–9.
Korn L, Haynie D, Luk J, Simons-Morton B. Prospective associations between cannabis use and negative and positive health and social measures among emerging adults. Int J Drug Policy. 2018;58:55–63.
Kozela E, Juknat A, Kaushansky N, Rimmerman N, Ben-Nun A, Vogel Z. Cannabinoids decrease the Th17 inflammatory autoimmune phenotype. J Neuroimmune Pharmacol. 2013;8(5):1265–76.
Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med. 2014;44(4):797–810.
Li P, Stuart EA, Allison DB. Multiple imputation. JAMA. 2015;314(18):1966.
Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction. 2000;95(11):1621–30.
Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet. 2004;363(9421):1579–88.
Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319–28.
Mota J, Esculcas C. Leisure-time physical activity behavior: structured and unstructured choices according to sex, age, and level of physical activity. Int J Behav Med. 2002;9(2):111–21.
Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009;1(7):1333–49.
Ong L, Bellettiere J, Alvarado C, Chavez P, Berardi V. Cannabis use, sedentary behavior, and physical activity in a nationally representative sample of US adults. Harm Reduct J. 2021;18:48.
Page RL, Allen LA, Kloner RA, Carriker CR, Martel C, Morris AA, et al. Medical marijuana, recreational Cannabis, and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2020;142(10):e131.
Pav M, Haesaert G, De Steur H. Public knowledge, perceptions, and behavioral intention regarding medical cannabis in Belgium. J Psychoactive Drugs. 2024;56(2):187–98.
Pesta DH, Angadi SS, Burtscher M, Roberts CK. The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance. Nutr Metab. 2013;10(1):71.
Pinckard K, Baskin K, Stanford K. Effects of exercise to improve cardiovascular health. Front Cardiovasc Med. 2019;6:69.
Reis JP, Bowles HR, Ainsworth BE, Dubose KD, Smith S, Laditka JN. Nonoccupational physical activity by degree of urbanization and U.S. geographic region. Med Sci Sports Exerc. 2004;35(12):2093–8.
SAS Institute Inc. SAS/STAT® 14.2 User’s Guide. Cary: SAS Institute Inc; 2016. [Online].
Schubert M, Hibbert J, Armenta R, Willis E, Ogle W. Cannabis and cannabidiol use in active individuals: a survey of timing and reasons for use. Med Sci Sports Exerc. 2022;54(9S):305.
Sciensano n.d. HIS - Health Interview Survey. [Online]. Available from: HYPERLINK "https://www.sciensano.be/en/projects/health-interview-survey" https://www.sciensano.be/en/projects/health-interview-survey. Cited 2023 08 26.
Shaw BA, Spokane LS. Examining the association between education level and physical activity changes during early old age. J Aging Health. 2008;20(7):767–97.
Smith L, Sheratt F, Barnett Y, Cao C, Tully M, Koyanagi A, et al. Physical activity, sedentary behaviour and cannabis use in 15,822 US adults. PublicHealth. 2021;193:76–82.
Smith PJ, Merwin RM. The Role of Exercise in Management of Mental Health Disorders: An Integrative Review. Annu Rev Med. 2020;72(1):45–62. https://doiorg.publicaciones.saludcastillayleon.es/10.1146/annurev-med-060619-022943.
The Lancet Regional Health- Europe. Debating the legalisation of recreational cannabis. Lancet Reg Health- Eur. 2021;10:100269.
Trost SG, Pate RR, Sallis JF, Freedson PS, Taylor WC, Dowda M, et al. Age and gender differences in objectively measured physical activity in youth. Med Sci Sports Exerc. 2002;34(2):350–5.
Van Eenoo P, Delbeke FT. The prevalence of doping in Flanders in comparison to the prevalence of doping in international sports. Int J Sports Med. 2003;24(8):565–70.
Van Oyen H, Van Der Heyden J, Perenboom R, Jagger C. Monitoring population disability: evaluation of a new Global Activity Limitation Indicator (GALI). Sozial-und Praventivmedizin. 2006;51(3):153–61.
Vansteelandt S, Daniel RM. On regression adjustment for the propensity score. Stat Med. 2014;33(23):4053–72.
Winhusen T, Theobald J, Kaelber DC, Lewis D. Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease. Drug Alcohol Depend. 2019;204:107557.
YorkWilliams SL, Gust CJ, Mueller R, Bidwell LC, Hutchison KE, Gillman AS, et al. The new runner’s high? Examining relationships between cannabis use and exercise behavior in states with legalized cannabis. Front Public Health. 2019;7:99.
YorkWilliams S, Gibson L, Gust C, Giordano G, Hutchison K, Bryan A. Exercise intervention outcomes with cannabis users and nonusers aged 60 and older. Am J Health Behav. 2020;44(4):420–31.
Acknowledgements
The authors wish to thank Lies Gremeaux together with the other members of the Unit Illicit Drugs (Sciensano) for their valuable feedback in the early stages of this project and for the valuable collaboration between Sciensano and Ghent University. The authors also thank Jérôme Antoine for proofreading the manuscript.
Funding
None to declare.
Author information
Authors and Affiliations
Contributions
BV: Conceptualization, formal analysis, investigation, methodology, project administration (supporting), software, visualization, validation, writing and editing the original draft. BD: Conceptualization, formal analysis (supporting), investigation (supporting), methodology (supporting), project administration, software (supporting), supervision, validation, reviewing. SV: formal analysis (supporting), investigation (supporting), methodology, project administration, software (supporting), supervision, validation, reviewing. LG: Data curation, resources, validation (supporting), reviewing. SD: Data curation, resources, validation (supporting), reviewing. ED: Conceptualization, formal analysis (supporting), investigation (supporting), methodology (supporting), project administration, resources, software (supporting), supervision, validation, reviewing.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Each edition of HIS data collection adhered to a protocol approved by the Ethical Committee of Ghent University (see chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/, https://www.sciensano.be/en/projects/health-interview-survey#procedure-for-accessing-the-health-interview-survey-microdata for the 2018 edition).
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Vernaillen, B., Devleesschauwer, B., Vansteelandt, S. et al. Cannabis use is not associated with altered levels of physical activity: evidence from the repeated cross-sectional Belgian Health Interview Survey. J Cannabis Res 7, 22 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s42238-025-00278-8
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s42238-025-00278-8